FDA Makes Rare Call, Removes Boxed Warning From Chantix, Zyban Labels
Executive Summary
Pfizer, GSK score as neuropsychiatric symptom risks now only appear in Warnings and Precautions section following EAGLES trial results.
You may also be interested in...
Chantix's Boxed Warning: Will A Positive Vote Justify A Negative Outcome?
FDA could use advisory committee members' comments to maintain the smoking cessation drug's boxed warning, even though they voted to remove it.
Pfizer's Pitch For Chantix Warning Reduction Focuses On Those With Mental Illness
Those patients need more options for smoking cessation, Pfizer says, but that is the group FDA most worries about when deciding whether to remove its boxed warning.
Was FDA Nit-Picking In Criticism Of Pfizer's EAGLES Trial?
When industry rep questioned whether problems with smoking cession drug trial were overestimated, FDA's rebuke was swift.